192 related articles for article (PubMed ID: 11771732)
1. Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2.
Honda M; Okuda T; Hasegawa T; Kurokawa M; Shiraki K; Matsuo K; Komatsuzaki M; Niimura M
Antivir Chem Chemother; 2001 Jul; 12(4):233-9. PubMed ID: 11771732
[TBL] [Abstract][Full Text] [Related]
2. Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy.
Daikoku T; Tannai H; Honda M; Onoe T; Matsuo K; Onoye Y; Nishizawa M; Kawana T; Okuda T; Hasegawa T; Shiraki K
J Dermatol Sci; 2016 Jun; 82(3):160-5. PubMed ID: 26917345
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
Bernstein DI; Ireland J; Bourne N
Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
[TBL] [Abstract][Full Text] [Related]
4. [Isolation of acyclovir-resistant strains of herpes simplex virus from clinical material].
L'vov ND; Andronova VL; Leont'eva NA; Galegov GA
Vopr Virusol; 1999; 44(6):247-9. PubMed ID: 10665057
[TBL] [Abstract][Full Text] [Related]
5. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
6. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient.
Pardeiro M; Cuenca-Estrella M; Fernández-Clúa MA; Santos-O'Connor F; Tabarés E; Gadea I
J Med Virol; 2004 May; 73(1):60-4. PubMed ID: 15042649
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Chibo D; Mijch A; Doherty R; Birch C
J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
[TBL] [Abstract][Full Text] [Related]
11. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
[TBL] [Abstract][Full Text] [Related]
12. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.
Kimberlin D; Powell D; Gruber W; Diaz P; Arvin A; Kumar M; Jacobs R; Van Dyke R; Burchett S; Soong SJ; Lakeman A; Whitley R
Pediatr Infect Dis J; 1996 Mar; 15(3):247-54. PubMed ID: 8852914
[TBL] [Abstract][Full Text] [Related]
13. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics.
Reyes M; Shaik NS; Graber JM; Nisenbaum R; Wetherall NT; Fukuda K; Reeves WC;
Arch Intern Med; 2003 Jan; 163(1):76-80. PubMed ID: 12523920
[TBL] [Abstract][Full Text] [Related]
14. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G
J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707
[TBL] [Abstract][Full Text] [Related]
16. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates.
Safrin S; Elbeik T; Mills J
J Infect Dis; 1994 Apr; 169(4):879-82. PubMed ID: 8133105
[TBL] [Abstract][Full Text] [Related]
17. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
[TBL] [Abstract][Full Text] [Related]
18. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
19. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
20. Recurrent antiviral-resistant genital herpes in an immunocompetent patient.
Kriesel JD; Spruance SL; Prichard M; Parker JN; Kern ER
J Infect Dis; 2005 Jul; 192(1):156-61. PubMed ID: 15942905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]